Application of Hollow Type Suppository to Pharmaceutical Preparation in Hospital I. Valproic Acid Suppository

The evaluation of valproic acid (VPA) hollow type suppository was carried out by a comparison between rectal and oral administration of VPA in 3 healthy volunteers and 10 patients. The oral dosage form was used as tablet or syrup of sodium valproate (VPA-Na) and a hollow type suppository containing...

Full description

Saved in:
Bibliographic Details
Published inByōin yakugaku Vol. 18; no. 4; pp. 338 - 342
Main Authors KATSUYAMA, YOSHIHIKO, SEKI, HIROSHI, HONGOU, KAZUHIRO, TSUBOUCHI, SHINJI, ZENDA, HIROSHI, WATANABE, YOSHITERU, TADA, AKIHIRO, MATSUMOTO, MITSUO, OSHIMA, SHUICHI, SHIOHARA, HISAO, KOBAYASHI, SHIGEAKI, MATSUMOTO, YOSHIAKI
Format Journal Article
LanguageJapanese
Published Japanese Society of Pharmaceutical Health Care and Sciences 1992
Subjects
Online AccessGet full text
ISSN0389-9098
2185-9477
DOI10.5649/jjphcs1975.18.338

Cover

Abstract The evaluation of valproic acid (VPA) hollow type suppository was carried out by a comparison between rectal and oral administration of VPA in 3 healthy volunteers and 10 patients. The oral dosage form was used as tablet or syrup of sodium valproate (VPA-Na) and a hollow type suppository containing VPA in the form of oily liquid was used for the rectal administration. A single oral dose of VPA-Na 7mg/kg or a single rectal dose of VPA 6.02mg/kg was administered to 3 healthy volunteers by a cross over study, respectively. The peak serum concentration (Cmax;45.24±4.84μg/ml) was reached within 1.7 hours after oral administration, while it was reached at 3.09 hours in the case of rectal administration (Cmax;41.28±1.21μg/ml). The areas under the curve of serum concentration (AUC) after oral and rectal administration were 887.76±182.03μg·h/ml and 1021.14±200.70μg·h/ml, respectively. Therefore, relative bioavailability (AUC rectal/AUC oral×100) was 115%. In patients after neurosurgical operation, relative bioavailability was over 88%.These data suggested that VPA was efficiently absorbed from the human rectum after the administration of hollow type suppository.Thus, it was concluded that VPA hollow type suppository could be useful for prophylaxis and management of seizure, especially for the patients who were not able to ingest the oral preparations.
AbstractList The evaluation of valproic acid (VPA) hollow type suppository was carried out by a comparison between rectal and oral administration of VPA in 3 healthy volunteers and 10 patients. The oral dosage form was used as tablet or syrup of sodium valproate (VPA-Na) and a hollow type suppository containing VPA in the form of oily liquid was used for the rectal administration. A single oral dose of VPA-Na 7mg/kg or a single rectal dose of VPA 6.02mg/kg was administered to 3 healthy volunteers by a cross over study, respectively. The peak serum concentration (Cmax;45.24±4.84μg/ml) was reached within 1.7 hours after oral administration, while it was reached at 3.09 hours in the case of rectal administration (Cmax;41.28±1.21μg/ml). The areas under the curve of serum concentration (AUC) after oral and rectal administration were 887.76±182.03μg·h/ml and 1021.14±200.70μg·h/ml, respectively. Therefore, relative bioavailability (AUC rectal/AUC oral×100) was 115%. In patients after neurosurgical operation, relative bioavailability was over 88%.These data suggested that VPA was efficiently absorbed from the human rectum after the administration of hollow type suppository.Thus, it was concluded that VPA hollow type suppository could be useful for prophylaxis and management of seizure, especially for the patients who were not able to ingest the oral preparations.
Author SHIOHARA, HISAO
SEKI, HIROSHI
TADA, AKIHIRO
ZENDA, HIROSHI
OSHIMA, SHUICHI
KOBAYASHI, SHIGEAKI
KATSUYAMA, YOSHIHIKO
MATSUMOTO, MITSUO
TSUBOUCHI, SHINJI
HONGOU, KAZUHIRO
MATSUMOTO, YOSHIAKI
WATANABE, YOSHITERU
Author_xml – sequence: 1
  fullname: KATSUYAMA, YOSHIHIKO
  organization: Department of Pharmacy, Shinshu University Hospital
– sequence: 1
  fullname: SEKI, HIROSHI
  organization: Department of Pharmacy, Toyoshina Red Cross Hospital
– sequence: 1
  fullname: HONGOU, KAZUHIRO
  organization: Department of Neurosurgery, Shinshu University School of Medicine
– sequence: 1
  fullname: TSUBOUCHI, SHINJI
  organization: Department of Pharmacy, Shinshu University Hospital
– sequence: 1
  fullname: ZENDA, HIROSHI
  organization: Department of Pharmacy, Shinshu University Hospital
– sequence: 1
  fullname: WATANABE, YOSHITERU
  organization: Department of Pharmaceutics, Showa College of Pharmaceutical Sciences
– sequence: 1
  fullname: TADA, AKIHIRO
  organization: Department of Pharmacy, Shinshu University Hospital
– sequence: 1
  fullname: MATSUMOTO, MITSUO
  organization: Department of Pharmaceutics, Showa College of Pharmaceutical Sciences
– sequence: 1
  fullname: OSHIMA, SHUICHI
  organization: Department of Neurosurgery, Shinshu University School of Medicine
– sequence: 1
  fullname: SHIOHARA, HISAO
  organization: Department of Pharmacy, Showa-inan General Hospital
– sequence: 1
  fullname: KOBAYASHI, SHIGEAKI
  organization: Department of Neurosurgery, Shinshu University School of Medicine
– sequence: 1
  fullname: MATSUMOTO, YOSHIAKI
  organization: Department of Pharmaceutics, Showa College of Pharmaceutical Sciences
BookMark eNp9kN9KwzAUh4NMcM49gHd5gdb8adrkcgznBgMHTm9LmqYuo2tC0iF7ezMqU3bhzTmcw_kOP757MOpspwF4xChleSae9nu3UwGLgqWYp5TyGzAmmLNEZEUxAmNEuUgEEvwOTEMwFSIU53FkY3CYOdcaJXtjO2gbuLRta7_g9uQ0fDs6Z4PprT_B3sLNTvqDVPrYx_sWbrx20g-g6SIYnOnjfpXCD9k6b42CM2Xqv28ewG0j26CnP30C3hfP2_kyWb--rOazdaIIozxhnAiVC8GIbriqmawKXtW80BQ1hCpKihoRnBGmqSaozjNMhKgYIbRQtOacTkAx_FXehuB1U6qY7Ry199K0JUblWVz5K67EvIziIomvSOfNQfrTv8xiYPahl5_6QkgfTbX6isiGEsHLgYpmS93Rb45dj34
CitedBy_id crossref_primary_10_1248_yakushi_16_00266
ContentType Journal Article
Copyright Japanese Society of Pharmaceutical Health Care and Sciences
Copyright_xml – notice: Japanese Society of Pharmaceutical Health Care and Sciences
DBID AAYXX
CITATION
DOI 10.5649/jjphcs1975.18.338
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2185-9477
EndPage 342
ExternalDocumentID 10_5649_jjphcs1975_18_338
article_jjphcs1975_18_4_18_4_338_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
OK1
RJT
AAYXX
CITATION
MOJWN
ID FETCH-LOGICAL-c2538-5829c69952ef8cd5ab78bd87e30f23c327d021425e3e20d641299b52237c3d883
ISSN 0389-9098
IngestDate Thu Apr 24 23:07:26 EDT 2025
Tue Jul 01 01:23:35 EDT 2025
Wed Sep 03 06:29:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2538-5829c69952ef8cd5ab78bd87e30f23c327d021425e3e20d641299b52237c3d883
OpenAccessLink https://www.jstage.jst.go.jp/article/jjphcs1975/18/4/18_4_338/_article/-char/en
PageCount 5
ParticipantIDs crossref_citationtrail_10_5649_jjphcs1975_18_338
crossref_primary_10_5649_jjphcs1975_18_338
jstage_primary_article_jjphcs1975_18_4_18_4_338_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1992
PublicationDateYYYYMMDD 1992-01-01
PublicationDate_xml – year: 1992
  text: 1992
PublicationDecade 1990
PublicationTitle Byōin yakugaku
PublicationTitleAlternate Japanese Journal of Hospital Pharmacy
PublicationYear 1992
Publisher Japanese Society of Pharmaceutical Health Care and Sciences
Publisher_xml – name: Japanese Society of Pharmaceutical Health Care and Sciences
References 3) 山岡清, 谷川原祐介著,“マイコンによる薬物速度論入門”, 南江堂, 東京, 1986, p562-178.
7) J. Thorpy, Neurology, 30, 1113-1114 (1980).
1) Y. Watanabe, Y. Tone, S. Nisihara and M. Matsumoto, J. Pharmacobio-Dyn., 9, 953-961 (1986).
2) 渡辺善照, 松本宜明, 松本光雄, 薬局, 40, 1599-1602 (1989).
5) F. Moolenaar, W. J. Greying, and T. Huizinga, Eur. J. Clin. Pharmacol., 17, 309-315 (1980).
6) F. J. E. Vajda, G. W. Mihaiy, J. L. Miles.(Hons), G. A. Donnan, and P. F. Bladin, Neurology, 28, 897-899 (1978).
4) 山岡清著,“マイコンによる薬物体内動態解析法”, 南江堂, 東京, 1982, p.92-94.
8) J. C. Cloyd and R. L. Kriel, Neurology, 31, 1348-1352 (1981).
References_xml – reference: 4) 山岡清著,“マイコンによる薬物体内動態解析法”, 南江堂, 東京, 1982, p.92-94.
– reference: 8) J. C. Cloyd and R. L. Kriel, Neurology, 31, 1348-1352 (1981).
– reference: 1) Y. Watanabe, Y. Tone, S. Nisihara and M. Matsumoto, J. Pharmacobio-Dyn., 9, 953-961 (1986).
– reference: 6) F. J. E. Vajda, G. W. Mihaiy, J. L. Miles.(Hons), G. A. Donnan, and P. F. Bladin, Neurology, 28, 897-899 (1978).
– reference: 5) F. Moolenaar, W. J. Greying, and T. Huizinga, Eur. J. Clin. Pharmacol., 17, 309-315 (1980).
– reference: 2) 渡辺善照, 松本宜明, 松本光雄, 薬局, 40, 1599-1602 (1989).
– reference: 3) 山岡清, 谷川原祐介著,“マイコンによる薬物速度論入門”, 南江堂, 東京, 1986, p562-178.
– reference: 7) J. Thorpy, Neurology, 30, 1113-1114 (1980).
SSID ssib023160985
ssib000937367
ssj0002504933
Score 1.2138224
Snippet The evaluation of valproic acid (VPA) hollow type suppository was carried out by a comparison between rectal and oral administration of VPA in 3 healthy...
SourceID crossref
jstage
SourceType Enrichment Source
Index Database
Publisher
StartPage 338
SubjectTerms hollow type suppository
management of seizure
prophylaxis of seizure
rectal absorption
rectal administration
relavtive bioavaliability
valproic acid
Title Application of Hollow Type Suppository to Pharmaceutical Preparation in Hospital I. Valproic Acid Suppository
URI https://www.jstage.jst.go.jp/article/jjphcs1975/18/4/18_4_338/_article/-char/en
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Hospital Pharmacy, 1992/08/20, Vol.18(4), pp.338-342
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfK4IEXxKcYX_ID2wNdQhvHjfOEQjeUUKkt0KLBS5TYDmsZ7bS1QuV_4X_lLk6TtAPEeGhUOb5L2_v1fHc-3xHyPAErlbUTbfkq8Szcv7WEi5URE6ld7mTgCOVZvv1OOHbfHvPjRuNnLWtpuUht-eO350r-R6owBnLFU7JXkGzJFAbgPcgXriBhuP6TjINq9zkPyINM59-b6Fo2sVsn5mPhFjqYl8OTjdD18Fybmt8m0XHdPKQZ2c2PySko1YlsBnKi6mw2tn9Xe12-Jw6BdpV8XX6BVxkC-DB-PRh3wyiPq4ZRv2q_PAoOg1wX9aIwej8odX0ANJ8w1I_LwQBowqhX3v181DdUSAL3qjAFprTW9BjYRJbfMs2mbZ2PgWHBLd8tOrhcUsRVlCHXqoyJ2gLNTDmubd3POy6WTp1Oz07kRdv3uN0WdklZr7O9tf6VWYngDyGTuGIRt0UMLK6R647ntTFjtPdOlCE8rP7mM9OAu_iKZt8cuby89EE2LJ8bUzD-14mDuS0zuk1uFU4IDQyi7pCGnt0l-wVGVgd0VB3Kuzig-3RY1Tdf3SPfarCj84wa2FGEHa3hhS7mdBN2tAY7OpnRNexoZNM17CjCrs7mPhm_ORp1Q6vo2mFJB1dPLhxfdnyfOzoTUvEk9USqhKdZK3OYZI6n8jp_XDPttFTHBYvTT8ENYJ5kSgj2gOzM5jP9kNDEUUwlaHJmymXgqKeZZL70fNHKFFdsl7TWv2gsi5L22FnlNP6jKHfJi5LkzNRz-dvkV0ZM5dTir7411TUXoCgn4JlJUFGPrvK4x-SmSQbHAN8TsrM4X-qnYPIu0mc58H4BDniryg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Application+of+Hollow+Type+Suppository+to+Pharmaceutical+Preparation+in+Hospital+I.+Valproic+Acid+Suppository&rft.jtitle=By%C5%8Din+yakugaku&rft.au=TSUBOUCHI%2C+SHINJI&rft.au=TADA%2C+AKIHIRO&rft.au=KATSUYAMA%2C+YOSHIHIKO&rft.au=ZENDA%2C+HIROSHI&rft.date=1992&rft.issn=0389-9098&rft.eissn=2185-9477&rft.volume=18&rft.issue=4&rft.spage=338&rft.epage=342&rft_id=info:doi/10.5649%2Fjjphcs1975.18.338&rft.externalDBID=n%2Fa&rft.externalDocID=10_5649_jjphcs1975_18_338
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0389-9098&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0389-9098&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0389-9098&client=summon